Singer Capital Markets is delighted to have been appointed as Nominated Adviser and Sole Broker to Directa Plus plc with immediate effect.
Singer Capital Markets has acted as Joint Broker to the company since 2018 and looks forward to continuing to support the Company as sole Broker.
About Directa Plus plc
Directa Plus has a unique and patented, chemical-free production process of pristine graphene nanoplatelets (GNPs), tailored to their partners’ and customers’ requirements. The manufacturing model is flexible and scalable. They have a pioneering vision of the applications of G+® Graphene Plus in different industrial sectors.
G+® is already at a commercial stage in the following markets: textile, environment, composites, elastomers and tires, battery and paints.
Ticker: DCTA
Market cap: £9.92 million
Website: Click here
*As at 19/11/2024
Let’s Talk
If you’re looking for more information about any of our services, or if you can’t find what you’re looking for directly on our site, please do not hesitate to contact us.
